Clinical trials of new drugs for Alzheimer disease - Huang, Li-Kai; Chao, Shu-Ping; Hu, Chaur-Jong (Journal of biomedical science, 2020)
Keywords: Advertising executives; Alzheimer disease; Alzheimer's disease; Amyloidosis; Anti-Alzheimer's disease agents; Anti-amyloid; Anti-tau; Aspartate; Atrophy; Biomarkers; Brain; Cholinesterase; Cholinesterase inhibitors; Clinical trials; Clinical trials of drugs; Cognitive ability; Dementia; Dementia disorders; Disease control; Diseases; Drug therapy; Drugs; Glutamate receptors; Hypotheses; Immunotherapy; Inflammation; Magnetic resonance imaging; Medical research; Memory; Metabolism; N-methyl-D-aspartate; N-Methyl-D-aspartic acid receptors; Neurodegeneration; Neurodegenerative diseases; Neuroinflammation; Neuroprotection; Neurotransmitters; Pathogenesis; Peptides; Pharmaceutical industry; Product development; Psychological symptoms; Reason; Review; Signs and symptoms; Tau protein; Time; Trends; United States--US; Neuroprotection; Anti-tau; Alzheimer disease; Anti-amyloid; Neuroinflammation; Cognitive enhancement; Clinical trials of drugs